Ameritas Investment Partners, Inc. A Tyr Pharma Inc Put Options Transaction History
Ameritas Investment Partners, Inc.
- $3.05 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LIFE
# of Institutions
117Shares Held
45.9MCall Options Held
684KPut Options Held
468K-
Federated Hermes, Inc. Pittsburgh, PA10.5MShares$19.6 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.66MShares$8.66 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY3.82MShares$7.11 Million2.7% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$4.58 Million1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA2.1MShares$3.9 Million0.0% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...